Design and Production of a Clinical Grade Retroviral Vector for a Phase I Clinical Study to Investigate Replacement Gene Therapy for the Treatment of Fanconi Anemia. - Fanconi Cancer Foundation

Supported Research

Design and Production of a Clinical Grade Retroviral Vector for a Phase I Clinical Study to Investigate Replacement Gene Therapy for the Treatment of Fanconi Anemia.

1999 | Research Grant | FRED HUTCHINSON CANCER RESEARCH CENTER

Amount Funded: $61,000

Researchers: Hans-Peter Kiem , Peter Kurre